Chemistry of Heterocyclic Compounds

, Volume 32, Issue 11–12, pp 1312–1318 | Cite as

Synthesis of various 5-(3-substituted phenyl)-2′-deoxyuridines

  • Ulf Wellmar
  • Anna-Britta Hörnfeldt
  • Salo Gronowitz
  • Nils Gunnar Johansson
Article
  • 30 Downloads

Abstract

A series pf 5-aryl-2′-deoxyuridines has been prepared and evaluated as antiviral agents. The following substituents have been used in position 3 of the phenyl ring: chloro, iodo, amino, azido, methylthio, and vinyl. None of the new compounds showed any significant activity when tested against human immunodeficiency virus 1 (HI V-I), herpes simplex virus 1 (HSV-I), or human cytomegalovirus (HCMV).

Keywords

Human Immunodeficiency Virus Organic Chemistry Phenyl Vinyl Herpes Simplex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. De Clercq, Targets for the Design pf Antiviral Agents, Proc. of the NATO Advanced Study Institute, Les Arcs, France, June 19–July 28, E. De Clercq and R. T. Walker (eds.), Plenum Press, New York-London (1984), p. 203.Google Scholar
  2. 2.
    U. Wellmar, A.-B. Hörnfeldt, S. Gronowitz, and N. G. Johansson, Antiviral Chemistry & Chemotherapy (Manuscript).Google Scholar
  3. 3.
    P. Wigerinck, R. Snoeck, P. Claes, E. De Clercq, and P. Herdewijn, J. Med. Chem.,34, 1767 (1991).Google Scholar
  4. 4.
    P. Wigerinck, C. Pannecouque, R. Snoeck, P. Claes, E. DeClercq, and P. Herdewijn, J. Med. Chem.,34, 2383 (1991).Google Scholar
  5. 5.
    P. Wigerinck, L. Kerremans, P. Claes, R. Snoeck, P. Maudgal, E. DeClercq, and P. Herdewijn, J. Med. Chem.,36, 538 (1993).Google Scholar
  6. 6.
    J. Liu, A. Van Aerschot, I. Luyten, P. Wigerinck, C. Pannecouque, J. Balzarini, E. De Clercq, and P. Herdewijn, Nucleosides Nucleotides,14, 525 (1995).Google Scholar
  7. 7.
    R. Betts, Prog. Med. Virol.,24, 44 (1982).Google Scholar
  8. 8.
    A. Macher, C. Reichert, S. Straus, D. Longo, J. Parillo, H. Lane, A. Fauci, A. Rook, J. Manischewitz, and G. Quinnan, N. Engl. J. Med.,309, 1454 (1983).Google Scholar
  9. 9.
    A. Tyms, D. Taylor, and J. Parkin, J. Antimicrob. Chemother.,23, Suppl. A, 89 (1989).Google Scholar
  10. 10.
    R. H. Rubin, Rev. Infect. Dis.,12, Suppl. 7, 754 (1990).Google Scholar
  11. 11.
    G. Schmidt, Transpl. Proc.,23, Suppl. 3, 126 (1991).Google Scholar
  12. 12.
    Collaborative DHPG Treatment Study Group, Engl. J. Med.,314, 801 (1986).Google Scholar
  13. 13.
    O. L. Laskin, C. M. Stahl-Bayliss, C. M. Kalman, and L. R. Rosecan, J. Infect.,155, 323 (1987).Google Scholar
  14. 14.
    J. P. H. Verhyden, Rev. Infect. Dis.,10, Suppl. 3 5477 (1988).Google Scholar
  15. 15.
    D. Faulds and R. C. Heel, Drugs,39, 597 (1990).Google Scholar
  16. 16.
    K. Knox, W. Dobryski, and D. Carrigan, Lancet,337, 1292 (1991).Google Scholar
  17. 17.
    T. Persson, A.-B. Hörnfeldt, S. Gronowitz, and N. G. Johansson, Antiviral Chem. Chemotherapy,7, 94 (1996).Google Scholar
  18. 18.
    U. Wellmar, A.-B. Hörnfeldt, S. Gronowitz, and N. G. Johansson, Antiviral Chem. Chemotherapy (Manuscript).Google Scholar
  19. 19.
    U. Wellmar, A.-B. Hörnfeldt, and S. Gronowitz, J. Heterocycl. Chem.,33, 409 (1996).Google Scholar
  20. 20.
    M. Hoffer, Chem. Ber.,93, 2777 (1960).Google Scholar
  21. 21.
    A. J. Hubbard, A. S. Jones, and R. T. Walker, Nucleic Acids Res.,12, 6827 (1984).Google Scholar
  22. 22.
    J. N. Frescos, Nucleotides Nucleotides,8, 549 (1989).Google Scholar
  23. 23.
    E. M. Acton, R. N. Goerner, H. S. Uh, K. J. Ryan, and D. W. Henry, J. Med. Chem.,22, 518 (1979).Google Scholar
  24. 24.
    S. Ya. Mel'nik, A. A. Bakhmedova, T. D. Miniker, I. V. Yartseva, M. N. Preobrazhenskaya, O. A. Zagulyaeva, V. P. Mamaev, E. V. Chekunova, and S. S. Marennikova, Bioorg. Khim.,10, 1645 (1981).Google Scholar
  25. 25.
    T. Yamaguchi and M. Saneyoshi, Chem. Pharm. Bull.,32 1441 (1984).Google Scholar
  26. 26.
    S. Kit, Microbiol. Sci.,2, 369 (1985).Google Scholar
  27. 27.
    G. A. Gentry, Pharmacol. Ther.,54, 319 (1992).Google Scholar
  28. 28.
    E. Littler, A. D. Stuart, and M. S. Chee, Nature,358, 160 (1992).Google Scholar
  29. 29.
    V. Sullivan, C. L. Talarico, S. C. Stanat, M. Davis, D. M. Coen, and K. K. Biron, Nature,358, 162 (1992).Google Scholar
  30. 30.
    N. G. Johansson and L. Vrang, Unpublished data.Google Scholar
  31. 31.
    A. Popescu, A.-B. Hörnfeldt, S. Gronowitz, and N. G. Johansson, Nucleotides Nucleotides,14, 1233 (1995).Google Scholar
  32. 32.
    W. A. Tatarowicz, N. S. Lurain, and K. D. Thompson, J. Virological Methods,35, 207 (1991).Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • Ulf Wellmar
  • Anna-Britta Hörnfeldt
  • Salo Gronowitz
  • Nils Gunnar Johansson

There are no affiliations available

Personalised recommendations